Conference
Inhibitor Development in Previously Untreated Patients with Severe Hemophilia a Treated with Nuwiq®, a New Generation Recombinant FVIII of Human Origin
Abstract
Abstract
Authors
Liesner R; Abashidze M; Aleinikova O; Altisent C; Belletrutti MJ; Borel-Derlon A; Carcao M; Chambost H; Chan A; Dubey L
Volume
128
Publisher
American Society of Hematology
Publication Date
December 2, 2016
DOI
10.1182/blood.v128.22.327.327
Conference proceedings
Blood
Issue
22
ISSN
0006-4971